Zolbetuximab (Vyloy): From Promising Drug to FDA Approval | Exclusive Interview with Astellas
24:06
Zolbetuximab (Vyloy): From Promising Drug to FDA Approval | Exclusive Interview with Astellas
5.3K viewsOct 24, 2024
YouTubeOncoDaily TV
Dr Klempner on the FDA Approval of Zolbetuximab for CLDN18.2+, HER2– Gastric or GEJ Adenocarcinoma
2:01
Dr Klempner on the FDA Approval of Zolbetuximab for CLDN18.2+, HER2– Gastric or GEJ Adenocarcinoma
691 viewsOct 22, 2024
YouTubeOncLive
GLEAM: biomarker and pharmacokinetic analyses of zolbetuximab in PAC
0:52
GLEAM: biomarker and pharmacokinetic analyses of zolbetuximab in PAC
45 views2 months ago
YouTubeVJOncology
What role will zolbetuximab play in treating gastric cancer?
1:44
What role will zolbetuximab play in treating gastric cancer?
805 viewsJan 23, 2023
YouTubeVJOncology
GLEAM: zolbetuximab plus gemcitabine and nab-paclitaxel in CLDN18.2-positive mPAC
1:48
GLEAM: zolbetuximab plus gemcitabine and nab-paclitaxel in CLDN18.2-positive mPAC
24 views1 month ago
YouTubeVJOncology
Targeting CLDN18.2 with zolbetuximab in gastric and GEJ cancer
2:08
Targeting CLDN18.2 with zolbetuximab in gastric and GEJ cancer
2K viewsJan 23, 2023
YouTubeVJOncology
Zolbetuximab & chemotherapy in claudin 18.2+ metastatic pancreatic cancer
0:35
Zolbetuximab & chemotherapy in claudin 18.2+ metastatic pancreatic cancer
72 views2 months ago
YouTubeVJOncology
1:31
LUCERNA: zolbetuximab, pembrolizumab, and chemotherapy in gastric cancer
155 views5 months ago
YouTubeVJOncology
2:59
NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
393 viewsOct 9, 2024
YouTubeNEJM Group
2:54
Phase II ILUSTRO: 1L zolbetuximab + mFOLFOX6 + nivolumab in CLDN18.2+ mG/GEJ cancer
139 views7 months ago
YouTubeVJOncology
See more
Static thumbnail place holder
You may also want to search